maintenance tirzepatide for the of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Question about "maintenance" dosing. How

The integration of microfluidics and zebrafish models represents not only improved experimental efficiency but also a conceptual shiftfrom testing single compounds to optimizing complex combination therapies

This phenomenon results in DCs losing the capability to release MHC class I and several pro-inflammatory cytokines in response to the maturation of lipopolysaccharide (LPS) and failing to stimulate CD8+ T cells to produce IFN-

Differential discontinuation from treatment was generally higher among patients in the semaglutide treatment groups than comparator groups, and were mostly the result of nausea and other GI AEs associated with semaglutide tablets

GLP-1 cannot be injected into everyone

FDA warning letter noted claims implying products are 'same' as FDA-approved drugs are misleading

What the research-use community reports